Daily Bulletin

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Reasons to opt for versatile gym bench by World Fitness AU

When it comes to exercise, having the appropriate gear may make all the difference in reaching your wellness and health objectives. A multifunctional gym bench is one of the most important pieces of...

Daily Bulletin - avatar Daily Bulletin

Mistakes to avoid while choosing professional-grade industrial cleaning supplies

Choosing the appropriate equipment is essential in the field of industrial cleaning to preserve a secure, and effective, as well as clean working environment. However, while selecting their professi...

Daily Bulletin - avatar Daily Bulletin

Finding the Right Façade Partner: Tips for Choosing the Best Cladding Systems Provider

The significance of making the right choice as far as the company that will provide your architectural cladding solution cannot be overemphasized especially while purchasing these systems for a corp...

Daily Bulletin - avatar Daily Bulletin